JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ELEK, S. R.
Right arrow Articles by KATZ, L. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ELEK, S. R.
Right arrow Articles by KATZ, L. N.
Journal of Pharmacology And Experimental Therapeutics, Vol. 74, Issue 4, 335-349, 1942
Copyright © 1942 by American Society for Pharmacology and Experimental Therapeutics


THE ACTION OF PAPAVERINE ON THE HEART OF THE DOG

STEPHEN R. ELEK 1 and L. N. KATZ 1

1 From the Cardiovascular Department, Michael Reese Hospital, Chicago

1. Papaverine depresses or annuls the responsiveness of the auricles to faradic stimulation.

2. In small doses it may augment A-V conductivity, but in larger doses it depresses A-V conductivity leading to partial or complete A-V block. Larger doses also cause intraventricular block.

3. It diminishes the irritability of the auricles and ventricles to extrinsic stimuli and prolongs the refractory period of the ventricles and auricles.

4. In the anesthetized dog breathing naturally and with natural beating of the heart, small doses of papaverine usually cause temporary sinus tachycardia. Larger doses lead to sinus slowing or standstill sometimes with nodal escapes or nodal rhythm, active ectopic ventricular rhythms and even ventricular flutter and fibrillation. Death with toxic doses is due to cardiac or ventricular standstill or to terminal ventricular fibrillation of a peculiar type.

5. The favorable action of this drug in reversing artificially induced ventricular fibrillation, and in diminishing or abrogating ventricular premature contractions electrically induced, is explained as due to a depression of conductivity and irritability and to a prolongation of the refractory period of the ventricles.

6. Evidence is presented to show that these are primarily direct effects on the heart.

7. The possible prophylactic and therapeutic clinical application of papaverine hydrochloride in the management of ectopic rhythms and ventricular fibrillation is suggested, but caution is advised inasmuch as this drug may cause the very arrhythmias for which it may be recommended.

Submitted on November 17, 1941




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
G. H. Whipple
Papaverine as an Antiarrhythmic Agent
Angiology, November 1, 1977; 28(11): 737 - 749.
[PDF]


Home page
Arch Intern MedHome page
R. S. MEGIBOW, L. N. KATZ, and P. M. FEINSTEIN
KINETICS OF RESPIRATION IN EXPERIMENTAL PULMONARY EMBOLISM
Arch Intern Med, April 1, 1943; 71(4): 536 - 546.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1942 by the American Society for Pharmacology and Experimental Therapeutics.